Search
인용 및 참조 문헌 (31)
Gibco™
CTS™ AIM V™ SFM
CTS AIM V SFM is a defined, serum-free medium (SFM) for the proliferation and/or manipulation of T cells, dendritic cells, and other immune cells manufactured in compliance with cGMP.
Have Questions?
보기 방식 변경
| 카탈로그 번호 | 수량 |
|---|---|
| 0870112DK | 1 L |
| 0870112BK | 10 L |
카탈로그 번호 0870112DK
제품 가격(KRW)
306,000
Each
수량:
1 L
제품 가격(KRW)
306,000
Each
Gibco Cell Therapy Systems (CTS) AIM-V SFM is a defined, serum-free medium specifically designed for the proliferation and/or manipulation of T cells, dendritic cells, and other immune cells that is manufactured in compliance with current Good Manufacturing Practice (cGMP) standards.
CTS AIM V SFM contains L-glutamine, 50 μg/mL streptomycin sulfate, and 10 μg/mL gentamicin sulfate.
CTS quality
Gibco CTS products are manufactured at a site that uses methods and controls that conform to cGMP for medical devices, 21 CFR Part 820. Our FDA-registered manufacturing sites are ISO 13485-certified. Gibco CTS products follow USP 'ancillary materials for cell, gene, and tissue-engineered products' within the responsibilities applicable to a supplier.*
Accompanied by documentation to support your regulatory filing
Specific intended-use statements, full documentation traceability, and convenient access to our Drug Master File (DMF) are available.
*Other aspects of USP will be the responsibility of the end-user to assess. Thermo Fisher Scientific cannot fulfill USP in regards to application and therapy-specific aspects (e.g., residual assessment and removal of the Ancillary Material).
For Research Use or Manufacturing of Cell, Gene, or Tissue-Based Products. CAUTION: Not intended for direct administration into humans or animals.
사양
세포 유형Monocytes, Dendritic Cells, T Cells, Hybridomas, PBMCs, Fibroblasts, Macrophages, Myeloma Cells, Lymphocytes
용도(애플리케이션)Cell and Gene Therapy Research, Development, and Manufacturing
형식Bottle
제조 품질ISO 13485, MDSAP, FDA-registered, 21 CFR 820
제품 유형Cell Culture Medium
수량1 L
유통 기한14 months from date of manufacture
배송 조건Ambient
분류Animal Origin
형태Liquid
Serum LevelSerum-free
멸균Sterile-filtered
Unit SizeEach
구성 및 보관
Store at 2–8°C and protect from light.
자주 묻는 질문(FAQ)
What is CTS?
What is the difference between AIM V Medium (Cat. Nos. 12055083, 12055091) and CTS AIM V SFM (Cat. Nos. 0870112DK, 0870112BK)?
What is the difference between CTS AIM-V Medium and CTS AIM V SFM?
인용 및 참조 문헌 (31)
인용 및 참조 문헌
Abstract
Live attenuated lentivirus infection elicits polyfunctional simian immunodeficiency virus Gag-specific CD8+ T cells with reduced apoptotic susceptibility in rhesus macaques that control virus replication after challenge with pathogenic SIVmac239.
Journal:J Immunol
PubMed ID:17878372
'HIV-specific CD8+ T cells that secrete multiple cytokines in response to Ag stimulation are associated with the control of virus replication during chronic HIV infection. To determine whether the presence of polyfunctional CD8+ T cell responses distinguishes protected and unprotected monkeys in a live attenuated lentivirus model, SIV Gag peptide-specific
Performance of serum-supplemented and serum-free media in IFNgamma Elispot Assays for human T cells.
Journal:Cancer Immunol Immunother
PubMed ID:19894047
'The choice of serum for supplementation of media for T cell assays and in particular, Elispot has been a major challenge for assay performance, standardization, optimization, and reproducibility. The Assay Working Group of the Cancer Vaccine Consortium (CVC-CRI) has recently identified the choice of serum to be the leading cause
[Study of adoptive immunotherapy for metastatic renal cell carcinoma with lymphokine-activated killer (LAK) cells and interleukin-2. II. Clinical evaluation]
Journal:Nippon Hinyokika Gakkai Zasshi
PubMed ID:8320888
'We evaluated adoptive immunotherapy using LAK cells combined with systemic administration of interleukin-2 (IL-2) in 11 patients with metastatic renal cell carcinoma. The LAK cells were generated by incubation in serum-free medium (AIM-V) supplemented with IL-2 (1,000 U/ml) for 4 days and were generally administered twice weekly (4 times/cycle). Daily
Serum-free culture medium and IL-7 costimulation increase the sensitivity of ELISpot detection.
Journal:J Immunol Methods
PubMed ID:18242633
'The identification of parameters maximizing detection sensitivity in ELISpot assays is important to transfer this technology into the clinical setting for identifying rare Ag-specific CD8(+) T cells. We have therefore considered human IFN-gamma CD8(+) T cell responses against viral epitopes to analyze different variables which could be critical during the
CD4 T cells guarantee optimal competitive fitness of CD8 memory T cells.
Journal:Eur J Immunol
PubMed ID:14971034
We studied the contribution of CD4 T cell help to survival and competitive fitness of CD8 memory T cells specific for influenza virus nucleoprotein. In agreement with recent studies, the optimal generation of functional memory CD8 T cells required CD4 help, although long-term maintenance of resting CD8 memory T cells